主页
AmCham China is privileged to announced its next Industrial Park Series program with the Taizhou National Medical Hi-Tech Development Zone (Also known as: China Medical City). The Industrial Park Series is a platform created for member company business leaders and China's local industrial park and development zones and local Chinese businesses to
Industrial parks and development zones are China's forefront engine of economic growth, and the utilization of foreign investment, application of cutting-edge technologies, and endeavors to pilot new policies and practices are inalienable to many parks' and zones' success stories. Documented in AmCham China's flagship annual White Paper and Business Climate Survey, many opportunities and challenges for American companies to do business in China are local, thus local governments, industrial parks and developments are critical stakeholders to exchange views on how to create a better business and investment environment for win-win partnerships.
Medical and pharmaceutical industries have great investment potential in China. AmCham China is pleased to invite you to join our event, to gain more understanding of policies and business opportunities in medical and pharmaceutical industries.
We are honored to invite several local FDA officers from Taizhou, and officers from Taizhou National Medical Hi-Tech Development Zone (Also known as: China Medical City) Administrative Committee. During the event, the following topics will be introduced by officers:
This is not a "please come and invest call!" The Zone's senior leadership and officials would like to keep their minds and ears open to hear and learn from AmCham China's member companies on your needs, and understand how better provide services to businesses.
- Discuss trending technologies, services and thought leadership that drive development of industries the zones and parks host,
- Exchange views on how local policies and industry planning can be made and executed to better service business growth.
Industrial parks and development zones are China's forefront engine of economic growth, and the utilization of foreign investment, application of cutting-edge technologies, and endeavors to pilot new policies and practices are inalienable to many parks' and zones' success stories. Documented in AmCham China's flagship annual White Paper and Business Climate Survey, many opportunities and challenges for American companies to do business in China are local, thus local governments, industrial parks and developments are critical stakeholders to exchange views on how to create a better business and investment environment for win-win partnerships.
Medical and pharmaceutical industries have great investment potential in China. AmCham China is pleased to invite you to join our event, to gain more understanding of policies and business opportunities in medical and pharmaceutical industries.
We are honored to invite several local FDA officers from Taizhou, and officers from Taizhou National Medical Hi-Tech Development Zone (Also known as: China Medical City) Administrative Committee. During the event, the following topics will be introduced by officers:
- General information of China Medical City
- Special medical and pharmaceutical industries policies in China Medical City
- Business opportunities in China Medical City
This is not a "please come and invest call!" The Zone's senior leadership and officials would like to keep their minds and ears open to hear and learn from AmCham China's member companies on your needs, and understand how better provide services to businesses.
